Literature DB >> 3971477

In vivo protection by protein A of hepatic microsomal mixed function oxygenase system of cyclophosphamide-treated rats.

M Dohadwala, P K Ray.   

Abstract

At a high dose, cyclophosphamide (Cy, 200 mg/kg) causes depression of the enzyme activity of the hepatic mixed function oxygenase (MFO) system in Sprague-Dawley rats. The present report provides evidence for the early regeneration of the depleted enzyme activity in Cy-treated rats by purified protein A (P) of Staphylococcus aureus. Enzymes of the MFO system, such as aminopyrine demethylase and aryl hydrocarbon hydroxylase, were assayed and the content of cytochrome P-450 was determined. Inoculation of P (60 micrograms/kg) prior to Cy inoculation provides a better effect than P administration after Cy. The exact mechanism of P action is unknown. P-treated animals appear to have an ability to repair the damage caused by the toxic metabolites of Cy earlier than those in the Cy group. This property of protein A may become useful in accelerated regeneration of the enzyme activity in the hepatic MFO system following the toxic insult of Cy metabolites.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3971477     DOI: 10.1007/bf00434352

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  27 in total

1.  HL-A-identical marrow transplants in aplastic anemia, acute leukemia, and lymphosarcoma employing cyclophosphamide.

Authors:  G W Santos; L L Sensenbrenner; P N Anderson; P J Burke; D L Klein; R E Slavin; B Schacter; D S Borgaonkar
Journal:  Transplant Proc       Date:  1976-12       Impact factor: 1.066

2.  Protein A from Staphylococcus aureus-a mitogen for human T lymphocytes and B lymphocytes but not L lymphocytes.

Authors:  T Sakane; I Green
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

3.  Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. X. Effect of treatment on tumor cell kinetics in mice.

Authors:  B Fisher; N Gunduz
Journal:  J Natl Cancer Inst       Date:  1979-06       Impact factor: 13.506

Review 4.  The history, properties, and function of NADPH-cytochrome P-450 reductase.

Authors:  B S Masters; R T Okita
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

5.  Protection by N-acetylcysteine of cyclophosphamide metabolism - related in vivo depression of mixed function oxygenase activity and in vitro denaturation of cytochrome P-450.

Authors:  M J Berrigan; H L Gurtoo; S D Sharma; R F Struck; A J Marinello
Journal:  Biochem Biophys Res Commun       Date:  1980-04-14       Impact factor: 3.575

Review 6.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

7.  Donor pretreatment in cadaver renal transplantation.

Authors:  H Zincke; J E Woods
Journal:  Surg Gynecol Obstet       Date:  1977-08

8.  Effect of frequency of plasma adsorption over protein A-containing Staphylococcus aureus on regression of rat mammary adenocarcinomas: modification of antitumor immune response and tumor histopathology.

Authors:  P K Ray; J Mohammed; P Allen; S Raychaudhuri; M Dohadwala; S Bandyopadhyay; R Mark
Journal:  J Biol Response Mod       Date:  1984

9.  gamma-Interferon induced by S. aureus protein A augments natural killing and ADCC.

Authors:  W J Catalona; T L Ratliff; R E McCool
Journal:  Nature       Date:  1981-05-07       Impact factor: 49.962

10.  Clinical use of immunosuppressive drugs: part II.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more
  6 in total

Review 1.  Stress genes and species survival.

Authors:  P K Ray
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

2.  A Simple & Convenient Solid Phase Synthesis of Bacterial Origin Octapeptide Sequence, Glu-Asp-Gly-Asn-Lys-Pro-Gly-Lys-OH.

Authors:  Riaz A Khan
Journal:  Int J Pept Res Ther       Date:  2010-03-03       Impact factor: 1.931

3.  Rescue of rats from large dose cyclophosphamide toxicity using protein A.

Authors:  P K Ray; M Dohadwala; S K Bandyopadhyay; P Canchanapan; D McLaughlin
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

4.  Aflatoxin induces depletion of activities of phase I biotransformation enzymes in growing rats.

Authors:  S Raisuddin; D Parmar; S I Zaidi; K P Singh; A S Verma; P K Seth; P K Ray
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Apr-Jun       Impact factor: 2.441

5.  Cysteine Supplementation Mitigates the Toxicity Associated with Antitumor Therapy of Ehrlich's Ascites Fluid Adsorbed over Protein A Containing Staphylococcus aureus Cowan I.

Authors:  Ashish S Verma; Anchal Singh; Priyadarshini Mallick; Premendra D Dwivedi
Journal:  J Pharm Bioallied Sci       Date:  2019 Jan-Mar

6.  Exogenous supplementation of N-acetylcysteine Can Reduce Hepatotoxicity Induced by Ascites Fluid (Cell-Free) Adsorbed Over Protein-A-Containing Staphylococcus aureus Cowan-I Without Compromising Its Antitumor Effect.

Authors:  Ashish S Verma; Priyadarshini Mallick; Premendra D Dwivedi; Anchal Singh
Journal:  J Pharm Bioallied Sci       Date:  2019 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.